🇺🇸 FDA
Patent

US 9072709

Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)

granted A61KA61K38/08A61K38/10

Quick answer

US patent 9072709 (Enhancement of bone morphogenic protein (BMP) retention with BMP binding peptide (BBP)) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/12, A61K38/1841